Rani R. Poli
Hyderabad, TG, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A prospective cohort study comparing efficacy of 1 dose of quadrivalent human papillomavirus vaccine to 2 and 3 doses at an average follow up of 12 years postvaccination.
Journal: Journal of the National Cancer Institute. Monographs
Published: April 02, 2024
Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine.
Journal: Human vaccines & immunotherapeutics
Published: December 11, 2023
Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study.
Journal: PloS one
Published: August 06, 2020
Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years - updated evidence from Indian follow-up cohort study.
Journal: Papillomavirus research (Amsterdam, Netherlands)
Published: November 12, 2018
Are two doses of human papillomavirus vaccine sufficient for girls aged 15-18 years? Results from a cohort study in India.
Journal: Papillomavirus research (Amsterdam, Netherlands)
Published: September 29, 2017
Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study.
Journal: The Lancet. Oncology
Published: July 22, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026